Who has been buying curexo stock?

3 distinct insiders have filed 18 disclosed insider purchases in curexo (060280), most recently on 2026-06-05. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.

How many insider filings does curexo have?

curexo has 18 buy-side and 0 sell-side disclosures on record, covering ₩1.1B ($780K) in total reported value, spanning 2024-07-12 to 2026-06-05.

Do insider buys in Korean stocks predict returns?

Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

curexo 060280

Company

큐렉소curexo

Insiders

Buys

Total Value

₩1.1B ($780K)

Avg Return

+101.26%

Last Filing

2026-06-05

curexo (060280) has 18 disclosed insider purchases and 0 disclosed disposals on record, filed by 3 distinct insiders. Together those filings cover ₩1.1B ($780K) in reported transaction value. The earliest filing StockDrifts holds for curexo is dated 2024-07-12; the most recent is 2026-06-05. Across these filings the average return since disclosure is +101.26%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

Date	Type	Source	Insider	Position	Shares	Price at filing	Return	Value
2026-06-05	BUY	Market Buy	이상훈 Lee Sang-hoon	Managing Director	1.6K	-	-	-
2026-06-04	BUY	Market Buy	이상훈 Lee Sang-hoon	Managing Director	3.4K	-	-	-
2026-03-03	BUY	주식매수선택권	임흥순 Lim Heung-soon	moving	10.0K	-	-	-
2026-03-03	BUY	주식매수선택권	김민진 Minjin Kim	moving	10.0K	-	-	-
2026-03-03	BUY	주식매수선택권	이상훈 Lee Sang-hoon	Managing Director	10.0K	-	-	-
2025-12-12	BUY	Market Buy	경기욱 Gyeonggi-wook	Outside Director	7.6K	₩13,610	+26.1%	₩103M ($72K)
2024-11-20	BUY	Market Buy	에치와이 HY	-	15.5K	₩7,080	+142.4%	₩110M ($76K)
2024-11-19	BUY	Market Buy	에치와이 HY	-	22.4K	₩7,080	+142.4%	₩158M ($110K)
2024-11-18	BUY	Market Buy	에치와이 HY	-	4.5K	₩6,480	+164.8%	₩29M ($20K)
2024-11-15	BUY	Market Buy	에치와이 HY	-	15.9K	₩6,300	+172.4%	₩100M ($70K)
2024-11-14	BUY	Market Buy	에치와이 HY	-	22.5K	₩6,140	+179.5%	₩138M ($96K)
2024-08-08	BUY	Market Buy	에치와이 HY	-	900	₩8,530	+101.2%	₩8M ($5K)
2024-08-07	BUY	Market Buy	에치와이 HY	-	10.5K	₩8,860	+93.7%	₩93M ($65K)
2024-08-06	BUY	Market Buy	에치와이 HY	-	17.2K	₩8,670	+97.9%	₩149M ($104K)
2024-08-02	BUY	Market Buy	에치와이 HY	-	1.5K	₩9,500	+80.6%	₩14M ($10K)
2024-07-31	BUY	Market Buy	에치와이 HY	-	300	₩9,920	+73.0%	₩3M ($2K)
2024-07-30	BUY	Market Buy	에치와이 HY	-	200	₩10,180	+68.6%	₩2M ($1K)
2024-07-26	BUY	Market Buy	에치와이 HY	-	1.6K	₩10,000	+71.6%	₩16M ($11K)
2024-07-25	BUY	Market Buy	에치와이 HY	-	1.2K	₩10,100	+69.9%	₩12M ($8K)
2024-07-24	BUY	Market Buy	에치와이 HY	-	17.5K	₩10,130	+69.4%	₩177M ($123K)
2024-07-12	BUY	Market Buy	에치와이 HY	-	1.0K	₩10,290	+66.8%	₩10M ($7K)

Frequently asked questions

Who has been buying curexo stock?: 3 distinct insiders have filed 18 disclosed insider purchases in curexo (060280), most recently on 2026-06-05. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does curexo have?: curexo has 18 buy-side and 0 sell-side disclosures on record, covering ₩1.1B ($780K) in total reported value, spanning 2024-07-12 to 2026-06-05.
Do insider buys in Korean stocks predict returns?: Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.